BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 15198743)

  • 1. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia].
    Zeidler C; Reiter A; Yakisan E; Koci B; Riehm H; Welte K
    Klin Padiatr; 1993; 205(4):264-71. PubMed ID: 7690865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
    Bönig H; Silbermann S; Weller S; Kirschke R; Körholz D; Janssen G; Göbel U; Nürnberger W
    Bone Marrow Transplant; 2001 Aug; 28(3):259-64. PubMed ID: 11535993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
    Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of recombinant human G-CSF in children with cancer].
    Tsukimoto I; Hanawa Y; Takaku F; Asano S; Ueda K; Tsuchida M; Sato T; Ohira M; Hoshi Y; Nishihira K
    Rinsho Ketsueki; 1990 Oct; 31(10):1647-55. PubMed ID: 1701501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
    Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
    Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
    Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients.
    Peddi VR; Hariharan S; Schroeder TJ; First MR
    Clin Transplant; 1996 Feb; 10(1 Pt 1):20-3. PubMed ID: 8652892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility of granulocyte colony-stimulating factor: early achievements and future promise.
    Morstyn G; Foote M; Perkins D; Vincent M
    Stem Cells; 1994; 12 Suppl 1():213-27; discussion 227-8. PubMed ID: 7535147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe congenital neutropenia: trends in diagnosis and therapy].
    Zeidler C; Schwinzer B; Welte K
    Klin Padiatr; 2000; 212(4):145-52. PubMed ID: 10994541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma.
    Hashino S; Morioka M; Irie T; Shiroshita N; Kawamura T; Suzuki S; Iwasaki H; Umehara S; Kakinoki Y; Kurosawa M; Kahata K; Izumiyama K; Kobayashi H; Onozawa M; Takahata M; Fujisawa F; Kondo T; Asaka M
    Int J Lab Hematol; 2008 Aug; 30(4):292-9. PubMed ID: 18665826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients.
    Heussner P; Haase D; Kanz L; Fonatsch C; Welte K; Freund M
    Int J Hematol; 1995 Dec; 62(4):225-34. PubMed ID: 8589368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on childhood neutropenias].
    Ueda K; Hanawa Y; Takaku F; Asano S; Tsukimoto I; Tsuchida M; Sato T; Ohira M; Hoshi Y; Nishihira K
    Rinsho Ketsueki; 1991 Mar; 32(3):212-20. PubMed ID: 1710294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital neutropenias.
    Zeidler C; Schwinzer B; Welte K
    Rev Clin Exp Hematol; 2003 Mar; 7(1):72-83. PubMed ID: 14692235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim).
    Ono M
    Eur J Cancer; 1994; 30A Suppl 3():S7-11. PubMed ID: 7535073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of filgrastim and lenograstim in pediatric solid tumors.
    Sarı N; Dalva K; Ilhan IE
    Pediatr Hematol Oncol; 2013 Oct; 30(7):655-61. PubMed ID: 24050764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V; Ongun H; Yeşilipek MA; Yeğin O
    Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.